Evolution of the Modified Rankin Scale and Its Use in Future Stroke Trials

Overview

Journal Stroke

Specialties Cardiology & Vascular Diseases
Neurology

Date 2017 Jun 20

PMID 28626052

Citations 283

Authors

Joseph P Broderick

Opeolu Adeoye

Jordan Elm

Affiliations

Soon will be listed here.

Citing Articles

Translation, validity and reliability of the Malay version of the adult carer quality of life questionnaire (AC-QOL) in informal caregivers of stroke survivors in Kelantan, Malaysia.

Khan E, Arifin W, Musa K BMC Public Health. 2025; 25(1):982.

PMID: 40075378 PMC: 11905460. DOI: 10.1186/s12889-025-22156-x.

Neuroprotective strategies in acute ischemic stroke: A narrative review of recent advances and clinical outcomes.

Zhao M, Qiao Y, Weiss A, Zhao W Brain Circ. 2025; 10(4):296-302.

PMID: 40012592 PMC: 11850939. DOI: 10.4103/bc.bc_165_24.

The economic impact of stent retriever selection for acute ischemic stroke: a cost analysis of MASTRO I from the healthcare system perspective of the United States, Canada and eight European countries.

Andersson T, Nordmeyer H, Brinjikji W, Kottenmeier E, Kabiri M, Scheffler S J Comp Eff Res. 2025; 14(3):e240216.

PMID: 39957470 PMC: 11864083. DOI: 10.57264/cer-2024-0216.

Description of STRIVE-ON Study Protocol: Safety and Tolerability of GTX-104 (Nimodipine Injection for IV Infusion) Compared with Oral Nimodipine in Patients Hospitalized for Aneurysmal Subarachnoid Hemorrhage (aSAH): A Prospective, Randomized, Phase....

Choi A, Chou S, Ducruet A, Kimberly W, Loch Macdonald R, Rabinstein A Neurocrit Care. 2025; .

PMID: 39875683 DOI: 10.1007/s12028-024-02207-8.

Predicting functional outcomes of patients with spontaneous intracerebral hemorrhage based on explainable machine learning models: a multicenter retrospective study.

Pan B, Li F, Liu C, Li Z, Sun C, Xia K Front Neurol. 2025; 15:1494934.

PMID: 39866516 PMC: 11757109. DOI: 10.3389/fneur.2024.1494934.

References

Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C . Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999; 282(21):2003-11. DOI: 10.1001/jama.282.21.2003. View

Feeny D . A utility approach to the assessment of health-related quality of life. Med Care. 2000; 38(9 Suppl):II151-4. DOI: 10.1097/00005650-200009002-00022. View

Rabin R, de Charro F . EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001; 33(5):337-43. DOI: 10.3109/07853890109002087. View

Wilson J, Hareendran A, Grant M, Baird T, Schulz U, Muir K . Improving the assessment of outcomes in stroke: use of a structured interview to assign grades on the modified Rankin Scale. Stroke. 2002; 33(9):2243-6. DOI: 10.1161/01.str.0000027437.22450.bd. View

Greenberg D, Pliskin J . Preference-based outcome measures in cost-utility analyses. A 20-year overview. Int J Technol Assess Health Care. 2002; 18(3):461-6. View

Prieto L, Sacristan J . Problems and solutions in calculating quality-adjusted life years (QALYs). Health Qual Life Outcomes. 2003; 1:80. PMC: 317370. DOI: 10.1186/1477-7525-1-80. View

Mendelow A, Gregson B, Fernandes H, Murray G, Teasdale G, Hope D . Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet. 2005; 365(9457):387-97. DOI: 10.1016/S0140-6736(05)17826-X. View

Wilson J, Hareendran A, Hendry A, Potter J, Bone I, Muir K . Reliability of the modified Rankin Scale across multiple raters: benefits of a structured interview. Stroke. 2005; 36(4):777-81. DOI: 10.1161/01.STR.0000157596.13234.95. View

Lees K, Zivin J, Ashwood T, Davalos A, Davis S, Diener H . NXY-059 for acute ischemic stroke. N Engl J Med. 2006; 354(6):588-600. DOI: 10.1056/NEJMoa052980. View

10.

Bath P, Gray L, Collier T, Pocock S, Carpenter J . Can we improve the statistical analysis of stroke trials? Statistical reanalysis of functional outcomes in stroke trials. Stroke. 2007; 38(6):1911-5. DOI: 10.1161/STROKEAHA.106.474080. View

11.

Shuaib A, Lees K, Lyden P, Grotta J, Davalos A, Davis S . NXY-059 for the treatment of acute ischemic stroke. N Engl J Med. 2007; 357(6):562-71. DOI: 10.1056/NEJMoa070240. View

12.

Farrell B, Godwin J, Richards S, Warlow C . The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry. 1991; 54(12):1044-54. PMC: 1014676. DOI: 10.1136/jnnp.54.12.1044. View

13.

Anderson C, Huang Y, Wang J, Arima H, Neal B, Peng B . Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol. 2008; 7(5):391-9. DOI: 10.1016/S1474-4422(08)70069-3. View

14.

Quinn T, Dawson J, Walters M . Dr John Rankin; his life, legacy and the 50th anniversary of the Rankin Stroke Scale. Scott Med J. 2008; 53(1):44-7. DOI: 10.1258/RSMSMJ.53.1.44. View

15.

Mayer S, Brun N, Begtrup K, Broderick J, Davis S, Diringer M . Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008; 358(20):2127-37. DOI: 10.1056/NEJMoa0707534. View

16.

Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D . Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008; 359(13):1317-29. DOI: 10.1056/NEJMoa0804656. View

17.

Quinn T, Dawson J, Walters M, Lees K . Reliability of the modified Rankin Scale: a systematic review. Stroke. 2009; 40(10):3393-5. DOI: 10.1161/STROKEAHA.109.557256. View

18.

Hong K, Saver J . Quantifying the value of stroke disability outcomes: WHO global burden of disease project disability weights for each level of the modified Rankin Scale. Stroke. 2009; 40(12):3828-33. PMC: 2788070. DOI: 10.1161/STROKEAHA.109.561365. View

19.

Torrance G, Furlong W, Feeny D . Health utility estimation. Expert Rev Pharmacoecon Outcomes Res. 2009; 2(2):99-108. DOI: 10.1586/14737167.2.2.99. View

20.

Rivero-Arias O, Ouellet M, Gray A, Wolstenholme J, Rothwell P, Luengo-Fernandez R . Mapping the modified Rankin scale (mRS) measurement into the generic EuroQol (EQ-5D) health outcome. Med Decis Making. 2009; 30(3):341-54. DOI: 10.1177/0272989X09349961. View